TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/12/24 17:46 | 7/10/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.d | -291 | 22.49 | 0 | -13 | -1 | 1,059 | D | ||||||||||||||
6/26/24 17:07 | 6/24/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.d | -299 | 23.10 | 0 | -13 | -1 | 1,059 | D | ||||||||||||||
2/12/24 20:22 | 2/8/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S | -2,496 | 27.13 | 0 | -92 | -8 | 1,059 | D | ||||||||||||||
1/25/24 16:59 | 1/23/24 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S | -105 | 18.41 | 0 | -6 | 0 | 1,151 | D | ||||||||||||||
1/8/24 16:19 | 12/15/23 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.m | -1,959 | 19.15 | 0 | -102 | -8 | 1,157 | D | ||||||||||||||
2/23/23 19:56 | 2/21/23 | FDMT | 4D Molecular Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | S.m | -710 | 20.61 | 0 | -34 | -2 | 1,859 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |